J. Andrew Case
Head of Clinical Supply Chain - Individualized Therapies, Genentech
Previously global business owner managing the Novartis business solution for the first to market CAR-T therapy. Subject matter expert in CAR-T Chain of Identity, order management, international supply chain solutions and technology development. Leading engagement with cellular therapy contract manufacturers as well as enabling commercial launches in 28 countries and counting.